Pelion Group Secures €25 Million Boost from EBRD
In a move that feels more like a blockbuster sequel than a business deal, the European Bank for Reconstruction and Development (EBRD) has just poured €25 million into Pelion Group, Poland’s heavyweight in pharma and cosmetics distribution.
Why This Matters
- The cash injection lets Pelion grab new assets and broaden its footprint across Poland and the Baltics.
- It also fuels exciting growth avenues – think telemedicine, e‑commerce, and a hodgepodge of fresh product lines.
- And, perhaps most brag‑worthy, it nudges the company nearer its lofty goal: becoming Europe’s top pharmaceutical distributor.
Inside the Conversation
Frederic Lucenet, EBRD Head of Manufacturing and Services, notes that this isn’t just a big check – it’s a statement of partnership:
“This is a very important transaction for the Bank. It strengthens the EBRD’s existing relationship with Pelion Group, which has ambitious plans to grow in the EBRD regions and elsewhere.”
“The Bank’s investment gives Pelion extra financial options, boosts confidence, and elevates quality standards for the Group’s expansion.”
“Pelion’s development of telemedicine and digital services will broaden healthcare access across Poland.”
“It’s a strategic investment that lines up with the Bank’s priorities in Poland to support innovation and digitalisation.” – Elisabetta Falcetti, EBRD Head of Poland and the Baltic states
In short, the EBRD is primed to help Pelion turn its big‑picture vision into a reality, stockpiling resources to widen wings both in the fight against disease and in the ushering of a digitally‑tuned medical marketplace.
Pelion Group: Poland’s Pharmacy Powerhouse
For over three decades, Pelion Group has been the go‑to name for pharmaceutical distribution in Poland, boasting a workforce of more than 11,500 people. It’s the kind of company that you’d trust to keep the medicine shelves stocked, the research labs humming, and the corporate finances balanced.
Behind the Curtain: The Retail Arm
Pelion’s retail side, CEPD, runs the show for the third‑largest pharmacy chain in the EU. Think about it—there are 1,660 stores spread across Poland, Lithuania, and Sweden. That’s like having a pharmacy on every corner of a continent, and each one is stocked to the brim.
Working Together With the EBRD
Since 2019, Pelion Group has been partnering with the European Bank for Reconstruction and Development (EBRD). The EBRD has been a major investor in Poland for nearly thirty years, pouring in more than €13.9 billion across 515 projects. Imagine that: we’re talking about a bank that’s literally cashing out the future of Polish business.
Pelion’s relationship with the EBRD is a clear win‑win: the bank’s capital fuels growth, and Pelion’s extensive distribution network helps that capital reach the people who need it.
Why Readers Might Care
- Pelion’s massive network guarantees you’ll find your meds—no matter where you live.
- With EBRD’s backing, the company can invest in cutting‑edge supply‑chain tech that keeps those pharmacy shelves high.
- As Poland’s largest pharmacy operator, Pelion sets a benchmark for efficiency and customer service across the EU.
So next time you pop into a pharmacy in Warsaw or Stockholm, remember: behind every bottle sits a powerhouse that’s been stepping up the game for over thirty years.
